Medco Health Solutions Inc.  

(Public, NYSE:MHS)   Watch this stock  
Find more results for MHS
0.00 (0.00%)
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 27.29B
P/E 19.39
Div/yield     -
EPS 3.63
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Dec '11) 2011
Net profit margin 2.24% 2.08%
Operating margin 3.55% 3.39%
EBITD margin - 4.53%
Return on average assets 9.63% 8.55%
Return on average equity 41.82% 36.41%
Employees 22,100 -
CDP Score - -


100 Parsons Pond Drive
United States - Map
+1-201-2693400 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Medco Health Solutions, Inc. (Medco) is a healthcare company. Medco provides clinically driven pharmacy services for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by Medicare Part D Prescription Drug Plans. Its Medco Therapeutic Resource Centers conduct therapy management programs using Medco Specialist Pharmacists, as well as Accredo Health Group. In addition, Medco has capabilities in post-approval safety and economics outcomes research, such as Risk Evaluation and Mitigation Strategies for biotechnology and other pharmaceutical drugs through its subsidiary, United BioSource Corporation (UBC). During the year ended December31, 2011, it administered 757 million prescriptions or 981 million adjusted prescriptions. The Company operates in two segments: Pharmacy Benefit Management and Specialty Pharmacy. On September 26, 2011, the Company acquired 50% in the Medco Celesio B.V. joint venture from Celesio AG.